Photo

613.801.1054

...

Ottawa

English, French

Louis Allard, Ph.D.

Senior Patent Agent

Louis joined MBM in April of 2022. He is a highly experienced patent agent with expertise in drafting and prosecuting patent applications worldwide. He is a registered Canadian Patent Agent and is also registered to represent Canadian patent applicants before the Unites States Patent and Trademark Office.

Louis's technical knowledge includes photovoltaics, quantum semiconductor devices, nuclear reactors, irradiation-based sterilization equipment, optical polarization, mobile devices, computer-implemented inventions, food preparation equipment, physical rehabilitation equipment, wastewater treatment systems, sterilization equipment, medical devices, heat exchangers, beverage dispensers, windows and doors, ophthalmology devices and horticulture systems.

Louis is also experienced in the preparation of patentability, infringement, and invalidity opinions.

In a previous career, Louis was a designer for optical measurement and control instruments. During this period, he was an inventor on four US patents.

Outside of work, Louis enjoys playing guitar in a jazz quartet and bass fishing.

EDUCATION

  • B.Sc. (Physics) - Université de Moncton
  • M.Sc. (Physics) - Université de Moncton
  • Ph.D. (Physics) - University of Ottawa

PROFESSIONAL INVOLVMENT

  • Appointed by the Commissioner of Patents to the Patent Agent Examination Board (patent drafting exam)
  • Intellectual Property Institute of Canada (IPIC)
  • College of Patent Agents & Trademark Agents (CPATA)

TECHNOLOGY AREAS

  • Nuclear energy
  • Solar energy
  • Electrical
  • Mechanical
  • Medical devices
  • Optical
  • Communications
  • Computer-implemented inventions

Practice Area

cb photo 103 56182ad806034

RANDALL MARUSYK

Partner


Randall is a partner of the firm and has been certified as a specialist in all areas of Canadian IP Law.
MBM read_more_btn

 

MBM logo

About MBM

 The process of invention is complete only with the IP protection provided in law. That's where MBM comes in. We match our clients' creative thinking with the creative protection needed to achieve their goals.Read More About MBM

Clarifications to the Data Protection Guidance Document

Health Canada recently announced that section 2.1 of its Guidance Document re: Data Protection has been amended to clarify that the prior approval of a medicinal ingredient in a drug for veterinary use will not preclude the granting of data protection for a drug for...Read More